We are pleased to share recent customer-provided third-party laboratory testing results from ILS Laboratories, USA, dated July 23, 2026.
Two peptide blend samples were analyzed using HPLC testing, with the following reported results:
- BPC-157 / TB-500 (20mg): 99.87% Peptide Purity
- CJC-1295 / Ipamorelin (10mg): 99.75% Peptide Purity
Both reports confirmed peptide identity through HPLC analysis. Fentanyl screening results were also reported as “Not Detected” at the specified testing cutoff.
[Insert Image 1: BPC-157 / TB-500 COA]
[Insert Image 2: CJC-1295 / Ipamorelin COA]
We appreciate customers who share laboratory testing results and value transparency, traceability, and independent analytical documentation in the research peptide industry.
Note: These laboratory results apply exclusively to the specific samples and batches tested. All peptides are intended for research use only, not for human consumption.
